13F COMBINATION REPORT (Amended)
METLIFE INC
Quarter ended Q2 2023 · Filed June 22, 2023 · Accession 0001140361-23-030940
Total Value
$13.1M
Positions
1
Other Managers
0
Confidential Omitted
No
Holdings (1)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CELLCOM ISRAEL LTD | M2196U109 | 196,385 | $13.1M | 100.00% |